Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
9 p, 1.5 MB Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS) : Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups / Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori) ; Hindi, Nadia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Cruz, Josefina (University Hospital Canarias) ; Blay, Jean-Yves (Center Leon Berard (Lyon)) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Italiano, Antoine (Institute Bergonie - Bourdeaux) ; Alvarez, Rosa (Hospital General Universitario Gregorio Marañón) ; Gutierrez, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Rincón, Inmaculada (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori) ; Pérez Aguiar, José Luis (Hospital Universitario Canarias) ; Romero, Jesús (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Morosi, Carlo (Fondazione IRCCS Istituto Nazionale dei Tumori) ; Sunyach, Marie Pierre (Center Leon Berard) ; Sanfilippo, Roberta (Fondazione IRCCS Istituto Nazionale dei Tumori) ; Romagosa, Cleofe (Hospital Universitari Vall d'Hebron) ; Ranchere-Vince, Dominique (Center Leon Berard) ; Dei Tos, Angelo (University of Padova) ; Casali, Paolo G. (University of Milan) ; Martin-Broto, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Universitat Autònoma de Barcelona
Myxoid liposarcoma (ML) exhibits a special sensitivity to trabectedin (T) and radiation therapy (RT). Preclinical data suggest a synergistic effect. We aimed to study safety, feasibility and activity of the administration of pre-operative concurrent T and RT in patients affected by localized resectable ML. [...]
2019 - 10.1016/j.eclinm.2019.03.007
EClinicalMedicine, Vol. 9 (march 2019) , p. 35-43  
2.
12 p, 577.5 KB Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic / Martín-Broto, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Hindi, Nadia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Aguiar Júnior, Samuel (A.C. Camargo Cancer Center. Department of Pelvic Surgery) ; Badilla-González, Ronald (Rafael Ángel Calderón Guardia Hospital. Department of medical oncology) ; Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima, Perú)) ; Chacón, Matias (Alexander Fleming Cancer Institute (Buenos Aires, Argentina)) ; Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; De Álava, Enrique (Universidad de Sevilla) ; Donati, Davide María (Rizzoli Orthopedic Institute) ; Eriksson, Mikael (Skåne University Hospital (Suècia)) ; Falla-Jimenez, Martin (Instituto Nacional de Enfermedades Neoplásicas (Lima, Perú)) ; German, Gisela (Hospital Oncológico Provincial (Córdoba, Argentina)) ; Gobo Silva, Maria Leticia (A.C. Camargo Cancer Center) ; Gouin, François (Centre León Bérard) ; Gronchi, Alessandro (University of Milan) ; Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima, Perú)) ; Jiménez-Brenes, Natalia (San Vicente de Paúl Hospital) ; Lopes de Mello, Celso Abdon (A.C. Camargo Cancer Center) ; Kasper, Bernd (Mannheim University Medical Cente) ; Maki, Robert G (University of Pennsylvania) ; Martínez-Delgado, Paula (Instituto de Biomedicina de Sevilla) ; Martínez-Said, Hector (Instituto Nacional de Cancerología (Ciutat de Mèxic)) ; Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Mèxic)) ; Morales-Pérez, Jose Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Muñoz-Casares, Francisco Cristobal (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Nakagawa, Suely A. (A.C. Camargo Cancer Center) ; Ortiz-Cruz, Eduardo Jose (Hospital Universitario La Paz (Madrid)) ; Palmerini, Emanuela (Rizzoli Orthopedic Institute) ; Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ; Moura, David S. (Insituto de Biomedicina de Sevilla) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Sunyach, Marie Pierre (Centre León Bérard) ; Valverde, Claudia M. (Hospital Universitari Vall d'Hebron) ; Waisberg, Federico (Alexander Fleming Cancer Institute (Buenos Aires, Argentina)) ; Blay, Jean-Yves (Centre León Bérard) ; Universitat Autònoma de Barcelona
Background: The COVID-19 outbreak has resulted in collision between patients infected with SARS-CoV-2 and those with cancer on different fronts. Patients with cancer have been impacted by deferral, modification, and even cessation of therapy. [...]
2020 - 10.1634/theoncologist.2020-0516
The Oncologist, Vol. 25 Núm. 10 (october 2020) , p. e1562-e1573  

Vegeu també: autors amb noms similars
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.